Abbott Laboratories (ABT) Cash from Operations (2009 - 2026)
Abbott Laboratories (ABT) posted Cash from Operations of 2488000000.0 for Q2 2026, up 89.2% sequentially from 1315000000.0 in Q1 2026, and up 21.54% YoY from 2047000000.0 in Q2 2025.
Abbott Laboratories (ABT) Cash from Operations (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Cash from Operations for 18 years, with the latest figure at 2488000000.0 in Q2 2026.
- Quarterly Cash from Operations rose 21.54% year-over-year to 2488000000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 9905000000.0 (up 9.6% YoY) and the FY2025 annual result came in at 9566000000.0, up 11.78% from the prior year.
- Cash from Operations advanced to 2488000000.0 in Q2 2026 per ABT's latest filing, from 1315000000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 3315000000.0 in Q4 2025 and troughed at 1025000000.0 in Q1 2024.
- A 5-year average of 2153833333.33 and a median of 2195500000.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations plunged 50.08% in 2023, then jumped 62.93% in 2024.
- Over 5 years, Cash from Operations stood at 2326000000.0 in 2022, then surged by 30.61% to 3038000000.0 in 2023, then retreated by 5.6% to 2868000000.0 in 2024, then climbed by 15.59% to 3315000000.0 in 2025, then retreated by 24.95% to 2488000000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 2488000000.0, 1315000000.0, and 3315000000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 447.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.49 Bn |
| Jun 30, 2026 | 2.49 Bn |
| Mar 31, 2026 | 1.32 Bn |
| Mar 31, 2026 | 1.32 Bn |
| Dec 31, 2025 | 3.32 Bn |
| Dec 31, 2025 | 3.32 Bn |
| Sep 30, 2025 | 2.79 Bn |
| Sep 30, 2025 | 2.79 Bn |
| Jun 30, 2025 | 2.05 Bn |
| Jun 30, 2025 | 2.05 Bn |
| Mar 31, 2025 | 1.42 Bn |
| Mar 31, 2025 | 1.42 Bn |
| Dec 31, 2024 | 2.87 Bn |
| Dec 31, 2024 | 2.87 Bn |
| Sep 30, 2024 | 2.71 Bn |
| Sep 30, 2024 | 2.71 Bn |
| Jun 30, 2024 | 1.96 Bn |
| Jun 30, 2024 | 1.96 Bn |
| Mar 31, 2024 | 1.03 Bn |
| Mar 31, 2024 | 1.03 Bn |